Atlas Trials

Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer

Clinical trial NCT05406999 · RECRUITING

Trial details

NCT number
NCT05406999
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Neoadjuvant TherapyHigh Risk Prostate CancerLocally Advanced Prostate CancerIntense Endocrine Therapy
Start date
2020-02-01
Primary completion
2026-12-31
Enrollment
900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.